Belgian pharma UCB today announced that the Phase III study investigating the safety and efficacy of adjunctive fenfluramine ...

US biopharma company Altimmune saw its share slump almost 55% to $3.48 yesterday, after it announced what it called ‘positive ...

US pharma major Merck & Co has secured a key endorsement for its newly approved respiratory syncytial virus (RSV) prevention ...

Rising use of innovative medicines and shifting spending patterns are reshaping the global pharmaceutical landscape, ...

US pharm giant Pfizer today announced positive top-line results from the Phase III BASIS study evaluating Hympavzi ...

US insurance giant Cigna has taken fresh legal action against Bristol Myers Squibb (NYSE: BMY), accusing the drugmaker of ...

Singapore-based biotech Hummingbird Bioscience has outlicensed its lead immunotherapy candidate, HMBD-002, to Australian drug ...

Bayer’s (BAYN: DE) cell therapy subsidiary BlueRock Therapeutics is shifting its priorities, cutting around 50 jobs and ...

Biogen’s salanersen has shown promise in slowing neuronal damage and opening new motor milestones, according to interim ...

The US Food and Drug Administration (FDA) has required and approved updates to the Prescribing Information for Comirnaty ...

Cambridge, USA-based ProFound Therapeutics today announced a four-year collaboration with Swiss pharma giant Novartis to ...

Australian biotech CSL Limited Europe-based subsidiary CSL Behring announced a milestone in the early benefit assessment of ...